Literature DB >> 19285890

Intravitreal bevacizumab for idiopathic choroidal neovascularization.

Mehmet Cakir1, Osman Cekiç, O Faruk Yilmaz.   

Abstract

An otherwise healthy 8-year-old girl with active juxtapapillary choroidal neovascularization was successfully treated with two intravitreal injections of bevacizumab. Intravitreal bevacizumab was well tolerated, choroidal neovascularization involuted, and subretinal and intraretinal serous fluid resorbed, with improvement in visual acuity from 20/400 to 20/50. The girl has remained stable for 6 months after the injections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285890     DOI: 10.1016/j.jaapos.2008.12.003

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  3 in total

1.  A case of idiopathic choroidal neovascular membrane in a young patient.

Authors:  M A Khan; Shabnam Bhalla; V S Gurunadh; V K Mohindra; Sridhara Reddy
Journal:  Med J Armed Forces India       Date:  2015-02-16

2.  Optical coherence tomography characteristics of responses to intravitreal bevacizumab in idiopathic choroidal neovascularization.

Authors:  Syed Nasir Ali Shah; Qian-Yan Kang; Xiao-Juan Fan; Yue-Ming Sun
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

3.  Idiopathic choroidal neovascular membrane in a young female.

Authors:  Saad Abdullah Waheeb; Mahmood Jameel Showail
Journal:  Oman J Ophthalmol       Date:  2009-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.